skip to main content
media conference

Press Releases

  • May 17, 2018

    Erectile dysfunction drugs and flu vaccine may work together to help immune system fight cancer after surgery, study finds

    A new study led by Dr. Rebecca Auer, a member of TFRI's Oncolytic Virus project and former recipient of a TFRI New Investigator Award, suggests that a common treatment for erectile dysfunction combined with the flu vaccine may be able to help the immune system mop up cancer cells left behind after surgery.

  • May 15, 2018

    Breakthrough test uses ctDNA to determine treatment resistance in advanced prostate cancer patients

    Metastatic castration-resistant prostate cancer (mCRPC) patients are now one step closer to more personalized treatment, thanks to a new test that can distinguish who will respond well to standard therapies and who will become resistant to treatment.

  • May 15, 2018

    Medulloblastoma leptomeningeal metastases can also occur through the bloodstream, study finds

    Findings from a recent study published in Cell are breaking new ground in the pediatric brain cancer world, suggesting medulloblastoma cells can metastasize in an entirely different way than previously assumed.

  • May 15, 2018

    Researchers develop groundbreaking targeted sequencing pipeline to further precision medicine in lymphoid cancers

    A cancer research team funded partly by The Terry Fox Research Institute has identified the best method for sequencing gene mutations across several of the most common forms of lymphoid cancer.

  • May 15, 2018

    Targeting hypoxia can, in turn, target cancer-initiating cells in colorectal tumours

    Targeting hypoxia can, in turn, target cancer-initiating cells (C-ICs) in colorectal cancer a study team in Toronto has found. Additionally, the team has discovered a biomarker for hypoxia to identify tumours that would most benefit from this innovative treatment method.

  • May 15, 2018

    Blocking donor T cell–mediated TNFα signaling can enhance positive effects of stem cell transplantation

    A collaboration between Swiss and Canadian research institutes has shown an effective way to enhance human hematopoietic stem and progenitor cell engraftment after stem cell transplantation by blocking donor T cell-mediated TNFα signalling.

  • May 14, 2018

    TFRI Now Seeking Applications for its 2019 Cancer Research Programs

    The Terry Fox Research Institute (TFRI) is seeking applications for two of its prestigious grant programs: The Terry Fox New Frontiers Program and the Terry Fox New Investigators Awards.

  • May 10, 2018

    TFRI-funded researchers uncover “evolutionary arms race” between cancer and immune system

    A new study led by a team of TFRI-funded researchers has uncovered the mechanisms through which deadly ovarian cancer cells escape the immune system, setting the stage for a better understanding of how and why patients respond to promising new immunotherapies.

  • May 01, 2018

    Canadian leaders in tumour hypoxia shed light on the role of mTOR signalling in prostate cancer development

    More findings from TFRI’s prestigious hypoxia team are continuing to change the cancer research landscape when it comes to understanding the role of the mTOR signalling pathway in the development and aggressiveness of prostate cancer.

  • April 25, 2018

    Schedule announced for Atlantic Node's Workshop on "The Many Ways to Science"

    TFRI's Atlantic node and the Beatrice Hunter Cancer Research Institute will hold a joint workshop on May 25 for researchers and students in Atlantic Canada on the subject of "The Many Ways to Science." All details for the meeting can be found at https://www.fourwav.es/view/672/info/ .

  • March 07, 2018

    Terry Fox Research Institute awards prestigious grant to help Manitoba cancer researcher tackle deadly brain cancer

    Brain cancer research in Manitoba has received a boost with news that a local scientist has won a prestigious cancer research award from the Terry Fox Research Institute. Dr. Sachin Katyal, a biologist at CancerCare Manitoba and the University of Manitoba, is the first researcher in Manitoba to receive the $450,000 Terry Fox New Investigator award for his “quick-to-clinic” personalized medicine approach to better treat patients with glioblastoma multiforme (GBM).

  • March 06, 2018

    Canadian pancreatic cancer research team provides personalized medicine, new hope to patients

    Canadian pancreatic cancer researchers are joining forces under a Terry Fox initiative bringing new hope for patients with this deadly disease.

  • February 15, 2018

    Therapeutic target EZH2 discovered for aggressive, untreatable ovarian cancer affecting young women

    A Vancouver team led by TFRI-funded investigator Dr. David Huntsman has discovered an important therapeutic target for treating small cell carcinoma of the ovary, hypercalcemic type (SCCOHT). This is a rare, but extremely lethal, ovarian cancer in young women with no effective treatment.

  • February 15, 2018

    Made-in-Canada model for detecting lung cancer saves lives, is a world leader

    A pan-Canadian TFRI team of cancer researchers has developed a predictive model for detecting early-stage lung cancer in high-risk individuals with significantly greater accuracy than other leading models. This study suggests the team’s innovative approach could be considered for use in lung cancer screening programs both in Canada and around the world.

  • February 15, 2018

    Nuclear mTOR acts as a transcriptional regulator of metabolism in prostate cancer, groundbreaking study finds

    A recent study by TFRI’s cancer metabolism group suggests nuclear mTOR (a kinase) also works as a transcriptional regulator of metabolism in the proliferation of prostate cancer.

Back to Top